SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001635698-16-000062
Filing Date
2016-02-10
Accepted
2016-02-10 16:28:20
Documents
1
Period of Report
2016-02-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4.html 4  
1 OWNERSHIP DOCUMENT form4.xml 4 15785
  Complete submission text file 0001635698-16-000062.txt   18797
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 161406095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889
Business Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 908-740-4000
Merck Sharp & Dohme Corp. (Reporting) CIK: 0000942443 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 161406094

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address WEYSTRASSE 20 LUCERNE 6 V8 CH-6000
Business Address WEYSTRASSE 20 LUCERNE 6 V8 CH-6000 41 58 618 16 16
Merck Sharp & Dohme Research GmbH (Reporting) CIK: 0001665244 (see all company filings)

State of Incorp.: V8
Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 161406093